Main Industry
Biotechnology
Main Product/Service
OncoTeller® integrates multiple proprietary genetic markers developed by MAO YING GENETECH INC., utilizing whole-genome microarrays for RNA quantification to deliver multiple answers from a single test.
The content above was translated by Ai
Founded Year
2012
Unified Business No.
53731167
Status
Active
Number of Employees
0
Total Paid-in
Capital
14,200,000 (NT$)
Location of Company
Taiwan
, Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups.
Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed.
Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
MAO YING GENETECH INC. was established in Taipei City in 2012 and was founded by Dr. Pei-Ying Huang. We possess our own uniquely developed bioinformatics algorithms, through which we analyze and validate big data from biomedical experiments to identify genetic markers that can be applied to disease diagnosis or assist in treatment.
For each research and development project, we first search for suitable data from the vast amount of experimental data stored in biomedical databases, and then use our self-developed algorithms to analyze the data, identify potential marker genes, and design validation methods. Next, we use more relevant biomedical experimental data to validate the genetic markers, and if good results are achieved, we cooperate with hospitals to conduct clinical validation.
For each research and development project, we first search for suitable data from the vast amount of experimental data stored in biomedical databases, and then use our self-developed algorithms to analyze the data, identify potential marker genes, and design validation methods. Next, we use more relevant biomedical experimental data to validate the genetic markers, and if good results are achieved, we cooperate with hospitals to conduct clinical validation.
The content above was translated by Ai
